Preferred Label : mirvetuximab soravtansine;
CISMeF synonym : IMGN853;
MeSH hyponym : IMGN-853;
UNII : 98DE7VN88D;
Origin ID : C000607289;
UMLS CUI : C4288736;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3592985/fr/elahere-mirvetuximab-soravtansine-cancer-de-l-ovaire
2025
false
false
false
France
insurance, health, reimbursement
mirvetuximab soravtansine
infusions, intravenous
adult
fallopian tube neoplasms
peritoneal neoplasms
Folate Receptor Alpha Positive
evaluation of the transparency committee
ovarian neoplasms
mirvetuximab soravtansine
---
https://www.has-sante.fr/jcms/p_3601719/fr/elahere-mirvetuximab-soravtansine-cancer-de-l-ovaire
2025
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
mirvetuximab soravtansine
mirvetuximab soravtansine
adult
ovarian neoplasms
fallopian tube neoplasms
peritoneal neoplasms
evaluation of the transparency committee
Folate Receptor Alpha Positive
---
https://www.ema.europa.eu/en/medicines/human/EPAR/elahere
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
treatment outcome
mirvetuximab soravtansine
mirvetuximab soravtansine
infusions, intravenous
drug approval
europe
ovarian neoplasms
fallopian tube neoplasms
peritoneal neoplasms
risk management
product surveillance, postmarketing
mirvetuximab soravtansine
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
Maytansinoid DM4
Mirvetuximab
premedication
pregnancy
breast feeding
tubulin modulators
tubulin modulators
folate receptor 1
Antibody-Drug Conjugates
immunoconjugates
drug evaluation, preclinical
Folate Receptor Alpha Positive
---
https://ansm.sante.fr/tableau-acces-derogatoire/elahere
2025
false
false
false
France
French
insurance, health, reimbursement
mirvetuximab soravtansine
mirvetuximab soravtansine
drug information
immunoconjugates
antibodies, monoclonal, humanized
maytansine
Antineoplastic Agents, Immunological
Folate Receptor Alpha Positive
ovarian neoplasms
peritoneal neoplasms
fallopian tube neoplasms
---